-
1
-
-
0032032069
-
Health related quality of life associated with lower urinary tract symptoms in four countries
-
Girman CJ, Jacobsen SJ, Tsukamoto T, et al.: Health related quality of life associated with lower urinary tract symptoms in four countries. Urology 1998, 51:428-433.
-
(1998)
Urology
, vol.51
, pp. 428-433
-
-
Girman, C.J.1
Jacobsen, S.J.2
Tsukamoto, T.3
-
2
-
-
0031023064
-
The International Continence Society Benign Prostatic Hyperplasia Study: The bothersomeness of urinary symptoms
-
Peters TJ, Donovan JL, Kay HE, et al.: The International Continence Society Benign Prostatic Hyperplasia Study: the bothersomeness of urinary symptoms. J Urol 1997, 157:885.
-
(1997)
J Urol
, vol.157
, pp. 885
-
-
Peters, T.J.1
Donovan, J.L.2
Kay, H.E.3
-
3
-
-
0035027148
-
BOO with coexisting overactive bladder dysfunction-an everyday urological dilemma
-
Knutson T, Edlund C, Fall M, Dahlstrand C: BOO with coexisting overactive bladder dysfunction-an everyday urological dilemma. Neurourol Urodyn 2001, 20:237-247.
-
(2001)
Neurourol Urodyn
, vol.20
, pp. 237-247
-
-
Knutson, T.1
Edlund, C.2
Fall, M.3
Dahlstrand, C.4
-
4
-
-
11144221994
-
Serum prostate specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms
-
Laniado ME, Ockrim JL, Marronaro A, et al.: Serum prostate specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int 2004, 94:1283-1286.
-
(2004)
BJU Int
, vol.94
, pp. 1283-1286
-
-
Laniado, M.E.1
Ockrim, J.L.2
Marronaro, A.3
-
5
-
-
0035664491
-
Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia
-
Eckhardt MD, van Verooij GE, Boon TA: Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia. Urology 2001, 58:966-971.
-
(2001)
Urology
, vol.58
, pp. 966-971
-
-
Eckhardt, M.D.1
Van Verooij, G.E.2
Boon, T.A.3
-
6
-
-
8144221209
-
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder
-
Lee JY, Kim HW, Lee SJ, et al.: Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004, 94:817. A sequential therapy trial using combination therapy in men initially stabilized on α-blockers.
-
(2004)
BJU Int
, vol.94
, pp. 817
-
-
Lee, J.Y.1
Kim, H.W.2
Lee, S.J.3
-
7
-
-
4544266557
-
Pharmacologic therapy of benign prostatic hyperplasia/ lower urinary tract symptoms: An overview for the practicing clinician
-
Chapple CR: Pharmacologic therapy of benign prostatic hyperplasia/ lower urinary tract symptoms: an overview for the practicing clinician. BJU Int 2004, 94:738.
-
(2004)
BJU Int
, vol.94
, pp. 738
-
-
Chapple, C.R.1
-
8
-
-
0034934163
-
Detrusor instability in men; correlation of lower urinary tract symptoms with urodynamic findings
-
Hyman MJ, Groutz A, Blaivas JG: Detrusor instability in men; correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001, 166:550.
-
(2001)
J Urol
, vol.166
, pp. 550
-
-
Hyman, M.J.1
Groutz, A.2
Blaivas, J.G.3
-
9
-
-
0035693995
-
Can urodynamic assessment of outflow obstruction predict outcome from watchful waiting? - A four year follow-up study
-
Knutson T, Schafer W, Fall M, et al.: Can urodynamic assessment of outflow obstruction predict outcome from watchful waiting? - A four year follow-up study. Scand J Urol Nephrol 2001, 35:463.
-
(2001)
Scand J Urol Nephrol
, vol.35
, pp. 463
-
-
Knutson, T.1
Schafer, W.2
Fall, M.3
-
10
-
-
0344431427
-
Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety concerns
-
abstract 1048
-
Abrams P: Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety concerns [abstract 1048]. J Urol 2002, 167(Suppl):266.
-
(2002)
J Urol
, vol.167
, Issue.SUPPL.
, pp. 266
-
-
Abrams, P.1
-
11
-
-
32044449411
-
Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction
-
Abrams P, Kaplan S, De Koning Gans HJ, Millard R: Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006, 175:999-1004. This is a very well-documented trial using thorough urodynamic evaluation to completely characterize outlet obstruction in treated men.
-
(2006)
J Urol
, vol.175
, pp. 999-1004
-
-
Abrams, P.1
Kaplan, S.2
De Koning Gans, H.J.3
Millard, R.4
-
12
-
-
0032768638
-
Bladder outlet obstruction index, bladder contractility index, and bladder voiding efficiency: Three simple indices to define bladder voiding function
-
Abrams P: Bladder outlet obstruction index, bladder contractility index, and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999, 84:14.
-
(1999)
BJU Int
, vol.84
, pp. 14
-
-
Abrams, P.1
-
13
-
-
0038286511
-
Combination treatment with an alpha blocker plus an anticholinergic for bladder outlet obstruction: A prospective, randomized, controlled study
-
Athanasopoulos A, Gyftopoulos K, Giannitsas K, et al.: Combination treatment with an alpha blocker plus an anticholinergic for bladder outlet obstruction: A prospective, randomized, controlled study. J Urol 2003, 169:2253-2256. This is a combination study with patients well-characterized with urodynamics. Also, it is a reasonable assessment of adverse event outcomes.
-
(2003)
J Urol
, vol.169
, pp. 2253-2256
-
-
Athanasopoulos, A.1
Gyftopoulos, K.2
Giannitsas, K.3
-
14
-
-
0031397010
-
Construction and validation of a short- Form benign prostatic hypertrophy health related quality of life questionnaire
-
BPH group in general practice
-
Lukacs B, Comet D, Grange JC, Thibault P: Construction and validation of a short- form benign prostatic hypertrophy health related quality of life questionnaire. BPH group in general practice. Br J Urol 1997, 80:722.
-
(1997)
Br J Urol
, vol.80
, pp. 722
-
-
Lukacs, B.1
Comet, D.2
Grange, J.C.3
Thibault, P.4
-
15
-
-
3042755102
-
A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence
-
Saito H, Yamada T, Oshima H, et al.: A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence. Jpn J Urol Surg 1999, 12:525-536.
-
(1999)
Jpn J Urol Surg
, vol.12
, pp. 525-536
-
-
Saito, H.1
Yamada, T.2
Oshima, H.3
-
16
-
-
24944527452
-
Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointerstinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: A prospective, randomized, controlled multicenter study
-
Lee K-S, Choo M-S, Kim D-Y, et al.: Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointerstinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study. J Urol 2005, 174:1334-1338. This is a study that uses sequential addition of antimuscarinic medication in men who failed initial therapy with α-blockade but showed substantial improvement in symptoms with combined therapy.
-
(2005)
J Urol
, vol.174
, pp. 1334-1338
-
-
Lee, K.-S.1
Choo, M.-S.2
Kim, D.-Y.3
-
17
-
-
27744523690
-
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia
-
Kaplan SJ, Walmsley K, Te A: Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 2005, 174:2273-2276. The only study to date of antimuscarinic treatment in men who have failed prior therapy for LUTS.
-
(2005)
J Urol
, vol.174
, pp. 2273-2276
-
-
Kaplan, S.J.1
Walmsley, K.2
Te, A.3
-
18
-
-
34848824466
-
Effects of tamsulosin and extended release oxybutynin on lower urinary tract symptoms in men
-
abstract 1639
-
Macdiarmid S, Chen A, Tu N, et al.: Effects of tamsulosin and extended release oxybutynin on lower urinary tract symptoms in men [abstract 1639]. J Urol 2006, 175:528. A combination study using initial therapy with both classes of medications rather than sequential addition.
-
(2006)
J Urol
, vol.175
, pp. 528
-
-
Macdiarmid, S.1
Chen, A.2
Tu, N.3
-
20
-
-
33644872094
-
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: Focus on the bladder
-
Chapple CR, Roehrborn CG: A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006, 49:651-659. A review commentary on the evolving understanding of male LUTS, including review of apropos use of nomenclature and role of urodynamic evaluation in patients with mixed symptoms.
-
(2006)
Eur Urol
, vol.49
, pp. 651-659
-
-
Chapple, C.R.1
Roehrborn, C.G.2
-
21
-
-
33748335370
-
Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systemic review
-
In press
-
Novara G, Galfano A, Ficarra V, Artibani W: Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: a systemic review. Eur Urol 2006, In press.
-
(2006)
Eur Urol
-
-
Novara, G.1
Galfano, A.2
Ficarra, V.3
Artibani, W.4
|